Search Results - Lilly Velentza

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth by Lilly Velentza, Malin Wickström, Per Kogner, Claes Ohlsson, Farasat Zaman, Lars Sävendahl

    Published in Scientific Reports (2023-05-01)
    Get full text
    Article


Search Tools: